About Us
Our team of experts includes scientists, researchers, physicians, business leaders, and lawyers who are dedicated to improving patient outcomes through innovation and collaboration.
By leveraging our relationships with industry leaders and extensive commercialization experience, we excel in providing innovative solutions that enhance efficiency, cut costs, and improve lives.
Our Focus
We are a clinical-stage biotechnology group specializing in toxicity science, lipid-based molecules, drug repurposing, and brain health. This multidisciplinary foundation supports the development of our lead clinical program, Cerebro-1, a rapid lipid-sink intervention designed to address acute cannabinoid intoxication and CHS.
Through integrated, novel approaches, we aim to deliver unified solutions that meet urgent medical needs and create meaningful impact for patients and healthcare systems.
